Tbx1 represses Mef2c gene expression and is correlated with histone 3 deacetylation of the anterior heart field enhancer

Autor: Alessandra Altomonte, Luna Simona Pane, Andrea Cirino, Rosa Ferrentino, Filomena Gabriella Fulcoli, Marchesa Bilio, Antonio Baldini
Přispěvatelé: Pane, Luna Simona, Fulcoli, Filomena Gabriella, Cirino, Andrea, Altomonte, Alessandra, Ferrentino, Rosa, Bilio, Marchesa, Baldini, Antonio
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Medicine (miscellaneous)
lcsh:Medicine
Histones
0302 clinical medicine
Immunology and Microbiology (miscellaneous)
MEF2C Gene
MEF2C
MEF2 Transcription Factors
Gene Expression Regulation
Developmental

Acetylation
Cell Differentiation
Heart
Tbx1
Cell biology
Anterior heart field enhancer
Mef2c
Histone
Enhancer Elements
Genetic

embryonic structures
Female
Research Article
lcsh:RB1-214
TBX1
Transgene
Induced Pluripotent Stem Cells
Neuroscience (miscellaneous)
Mice
Transgenic

Biology
General Biochemistry
Genetics and Molecular Biology

Cell Line
03 medical and health sciences
stomatognathic system
DiGeorge Syndrome
lcsh:Pathology
Animals
Humans
Enhancer
Transcription factor
Biochemistry
Genetics and Molecular Biology (all)

Base Sequence
Myocardium
lcsh:R
Embryo
Mammalian

GATA4 Transcription Factor
030104 developmental biology
biology.protein
T-Box Domain Proteins
030217 neurology & neurosurgery
Zdroj: Disease Models & Mechanisms, Vol 11, Iss 9 (2018)
Disease models & mechanisms
11 (2018). doi:10.1242/dmm.029967
info:cnr-pdr/source/autori:Pane L.S.; Fulcoli F.G.; Cirino A.; Altomonte A.; Ferrentino R.; Bilio M.; Baldini A./titolo:Tbx1 represses Mef2c gene expression and is correlated with histone 3 deacetylation of the anterior heart field enhancer/doi:10.1242%2Fdmm.029967/rivista:Disease models & mechanisms (Print)/anno:2018/pagina_da:/pagina_a:/intervallo_pagine:/volume:11
Disease Models & Mechanisms
ISSN: 1754-8411
1754-8403
DOI: 10.1242/dmm.029967
Popis: The TBX1 gene is haploinsufficient in 22q11.2 deletion syndrome (22q11.2DS), and genetic evidence from human patients and mouse models points to a major role of this gene in the pathogenesis of this syndrome. Tbx1 can activate and repress transcription, and previous work has shown that one of its functions is to negatively modulate cardiomyocyte differentiation. Tbx1 occupies the anterior heart field (AHF) enhancer of the Mef2c gene, which encodes a key cardiac differentiation transcription factor. Here, we show that increased dosage of Tbx1 correlates with downregulation of Mef2c expression and reduced acetylation of its AHF enhancer in cultured mouse myoblasts. Consistently, 22q11.2DS-derived and in vitro-differentiated human induced pluripotent stem cells (hiPSCs) expressed higher levels of MEF2C and showed increased AHF acetylation, compared with hiPSCs from a healthy donor. Most importantly, we show that in mouse embryos, loss of Tbx1 enhances the expression of the Mef2c-AHF-Cre transgene in a specific region of the splanchnic mesoderm, and in a dosage-dependent manner, providing an in vivo correlate of our cell culture data. These results indicate that Tbx1 regulates the Mef2c AHF enhancer by inducing histone deacetylation.
Summary: Using three experimental models, we demonstrate that Tbx1 suppresses Mef2c gene expression, and show that histone 3 acetylation of the anterior heart field enhancer of the Mef2c gene responds negatively to Tbx1 dosage.
Databáze: OpenAIRE